Skip to main content
OpenTrials

Clinical trial condition

Eosinophilic Granulomatosis With Polyangiitis

Explore clinical trials studying Eosinophilic Granulomatosis With Polyangiitis. Study availability and eligibility vary by location and protocol.

11 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Eosinophilic Granulomatosis With Polyangiitis trial results

Recruiting

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

NCT00315380

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • University of California San Diego San Diego, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 13 locations
View Trial Details
Recruiting

VCRC Tissue Repository

NCT02967068

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +48 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

NCT04551989

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Gunma, Japan
  • GSK Investigational Site Hyōgo, Japan
  • GSK Investigational Site Hyōgo, Japan
View all 34 locations
View Trial Details
Completed

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

NCT03298061

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Bethesda, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

NCT05263934

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Gainesville, Florida, United States
  • GSK Investigational Site Rochester, Minnesota, United States
  • GSK Investigational Site New York, United States
View all 63 locations
View Trial Details
Active, Not Recruiting

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

NCT06046222

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • National Jewish Health Denver, Colorado, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View all 34 locations
View Trial Details

Related conditions